Aligos Therapeutics
ALGS
ALGS
35 hedge funds and large institutions have $20.6M invested in Aligos Therapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.64M | |
| 2 | +$278K | |
| 3 | +$114K | |
| 4 |
D.E. Shaw & Co
New York
|
+$83.3K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
+$82.1K |
Top Sellers
| 1 | -$848K | |
| 2 | -$437K | |
| 3 | -$397K | |
| 4 |
Jane Street
New York
|
-$226K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$111K |
